CALC CalciMedica, Inc. Common Stock

XNAS 0.69 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CALC $0.69 —
Key stats
$0.69
52-Week Range
$1.00 – $36.00
YTD
-97.95%
Straddle Price
$2.48
P/C Vol Ratio
0.10
Market Cap
$0.0B
Open
$1.26
Day Range
$1.25 – $1.50
Volume
157,985
Prev Close
$1.23
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.69
Cost of Equity (CAPM)8.41% (VRP-adj)
WACC7.49%
Volatility Risk Premium+398.8pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-385.3%
Book / Price26.4%
Debt / Equity1.67
Quality Score0/6 — cyclical/struggling (5y DCF)
SMA 50$1.88 (Market Anchor value)
SMA 20 / Bollinger Mid$1.30
Bollinger Width / SMA205112.9% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABT, NVS, PFE (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
33%
20-Day Fair Value
≈ by Nov 25, 2026
$1.31
α +0.4% rank 85%
conviction
28%
40-Day Fair Value
≈ by Dec 24, 2026
$1.31
α +0.5% rank 82%
conviction
15%
60-Day Fair Value
≈ by Jan 22, 2027
$1.31
α +0.9% rank 81%
conviction
33%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 39.5× · 3 peers
Peer EV/EBITDA n/a 0% median 19.2× · 3 peers
Peer P/B $1.20 19% median 3.5× · 3 peers
Peer P/S n/a 0% median 3.9× · 3 peers
Market Anchor (SMA50) $1.88 81% stability 85% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-27 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
15
List Date
2020-09-25
CIK
0001534133
Next Earnings
2026-11-11 (After-Close)
EPS Forecast
($0.75) (1 est.)
Headquarters
La Jolla, CA
Homepage
https://www.calcimedica.com

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'23'24'25'26Avg
Jan--142.74%-22.19%-86.65%11.30%
Feb---29.35%-15.91%-22.94%-22.73%
Mar-21.01%-6.94%-13.18%6.51%-8.66%
Apr9.94%45.80%-19.49%0.31%9.14%
May7.89%-4.70%10.32%38.80%13.08%
Jun-15.76%-30.40%-2.44%22.33%-6.57%
Jul-10.94%9.88%120.51%-3.85%28.90%
Aug-7.01%-6.92%-8.16%-43.14%-16.31%
Sep-17.26%-1.34%-0.78%-19.00%-9.60%
Oct-11.65%-12.53%-3.27%-21.21%*-12.17%
Nov93.02%-1.71%42.81%--44.71%
Dec-27.23%3.21%53.61%--9.86%
Total-32.88%38.19%109.88%-93.49%5.43%
* Only 4 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.30
SMA 50: $1.88
SMA 200: $4.55
Current: $1.30
EMA 12: $1.22
EMA 26: $1.44
MACD: -0.2210 | Signal: 0.0510
BEARISH
ADX (14): 45.34
STRONG TREND
+DI: 22.08
−DI: 21.85

Momentum Oscillators

RSI (14): 40.20
NEUTRAL
Stoch %K: 40.57
Stoch %D: 28.83
Williams %R: -40.00

Volume & Volatility

BB Upper: $1.73
BB Lower: $0.87
NEUTRAL
OBV: -21,681,876
Vol SMA 20: 74,067
Vol ROC: 110.43%
ATR: $0.16
True Range: $0.27
HV 20: 79.1%
HV 30: 66.3%
HV 60: 100.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

SYMBOL: CALC

Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 6/10) Key Drivers:

  • Technical indicators suggest a neutral market with no clear trend
  • Recent news headlines show mixed sentiment, with no significant catalysts impacting the stock price

Primary Risks:

  • Low volatility and beta indicate low risk, but could also mean limited upside potential
  • Options market pricing suggests a $0.50 move by expiration, which may not be significant enough to drive meaningful returns

2-3 sentence investment thesis: Calcimedica (CALC) presents a neutral investment opportunity with no clear direction or catalysts driving the stock price. While the company has shown promise in its CARPO trial for Auxora™ in acute pancreatitis, recent news headlines have been mixed and may not be enough to move the needle significantly.

Recent News Sentiment Impact: The most significant recent news headline is the announcement of the first patient enrolled in the international expansion of the CARPO trial (GlobeNewswire Inc., 2023-08-09). This neutral sentiment event did not appear to impact the stock price significantly.

Technical Analysis Trend Direction:

  • Short-term: Neutral (no clear trend)
  • Medium-term: Uptrend (SMA 50 above SMA 20 and 200)
  • Long-term: Downtrend (SMA 200 below SMA 50 and 20)

Support/Resistance Levels:

  • Key price levels to monitor include the upper Bollinger Band ($0.89), middle band ($0.67), and lower band ($0.46).

Momentum Signals:

  • RSI (14): Neutral at 36.60
  • MACD: Bearish with a histogram of -0.21

Volume Analysis:

  • Volume SMA 20: 293624.39
  • On-Balance Volume (OBV): -49807898.00
  • Volume Rate of Change: -43.01%

News & Sentiment Analysis Recent Headlines Summary: The most recent news headlines are neutral, with no clear trend or catalyst driving the stock price.

Sentiment Assessment: Aggregate news sentiment is NEUTRAL due to mixed signals from various sources.

Catalyst Identification: There are no immediate (1-7 days) or near-term (1-4 weeks) catalysts that could significantly impact the stock price.

Market Narrative: The market narrative suggests a neutral market with no clear direction, which aligns with the technical indicators and news sentiment.

Risk & Volatility Assessment Beta Interpretation: CALC has a low beta of 0.30 compared to SPY, indicating low risk relative to the overall market.

Volatility Regime: Current volatility is low (1.34), with no significant changes expected in the near term.

Options Market Signals: IV Rank: Medium (42.4%), indicating historically average volatility Put/Call Volume Ratio: Neutral (1.22), suggesting no strong sentiment bias

Downside Protection: Support levels to monitor include the lower Bollinger Band ($0.46) and SMA 20 ($0.67).

Market Context & Positioning Sector Performance: CALC is performing similarly to its sector peers, with no significant relative strength or weakness.

Institutional Activity: There is moderate institutional interest in CALC, with a volume flow of 18 calls vs 22 puts.

Correlation Analysis: CALC has a low correlation (0.04) with the overall market, indicating limited sensitivity to broader market movements.

Relative Valuation: CALC is trading near its long-term moving averages, suggesting no clear relative value or over/under valuation.

Key Levels & Action Items Critical Price Levels:

  • Upper Bollinger Band ($0.89)
  • Middle band ($0.67)
  • Lower band ($0.46)

Breakout/Breakdown Levels:

  • SMA 20 ($0.67) and SMA 50 ($1.03)

Time-Sensitive Catalysts: No immediate or near-term catalysts are expected to significantly impact the stock price.

Risk Management: Stop-loss levels should be set at the lower Bollinger Band ($0.46), with position sizing considerations based on volatility and beta.

Data Interpretation Guidelines RSI: 36.60 (neutral) MACD: Bearish with a histogram of -0.21 Moving Averages: No clear trend direction

News Impact Assessment: Recent news headlines are neutral, with no significant impact on the stock price.

Risk Assessment Criteria: High Risk: None Medium Risk: None Low Risk: Low volatility and beta indicate low risk

Output Format Requirements Be Objective: Present both bullish and bearish cases. Use Specific Data: Reference actual numbers from technical indicators. Highlight Conflicts: Note when technical and news signals diverge. Assess Data Quality: Comment on data completeness and reliability.

This comprehensive analysis provides a neutral investment thesis for CALC, highlighting the importance of monitoring key price levels, institutional activity, and options market signals. The report also notes the low risk profile of the stock, which may not be sufficient to drive meaningful returns in the near term.

Generated
Earnings History
2 of 2 under expected move
Avg Expected Move
253.55%
Avg Actual Move
13.90%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2023-11-02 After-Close 334.74% 20.25% 0.06x Within
2026-03-03 After-Close 172.35% 7.55% 0.04x Within

Earnings calendar: this week’s reports with expected vs actual moves →

CALC Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $2.48
7-DTE Move: $2.48
Days to Exp: 1 (2026-07-17)

Options Flow

Call Volume: 187
Put Volume: 18
P/C Volume: 0.096
BULLISH
Call OI: 2,760
Put OI: 7
P/C OI: 0.003
Total OI: 2,767

ATM Options Pricing

ATM Call: $0.03
ATM Put: $2.45
Call %: 3.6%
Put %: 355.0%

Chain Summary

Chain Volume: 205
Chain OI: 2,767
Last Updated: 7/16/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Not enough history yet to rank today's net dealer gamma against this name's own record.

Gamma percentile
—
vs own history
GEX tilt
+0.28
OI-weighted, today
Vanna tilt
+0.28
δ-sensitivity to IV
Charm tilt
-0.20
δ-decay vs time

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 3 ATM contracts, 1k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jul 15 · No data
30 DTE / 10d —
— pts EXTREME
as of Jul 15 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$2.48Jul 16
Beta Analysis

Risk Metrics

Beta: 0.6464
Alpha: -114.55%
Correlation: 0.0573
R-Squared: 0.3%
Stock Volatility: 143.7%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own CALC
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$100K
0.00%
#2977 of 3138-24.0%13F
Rockefeller Capital Management Family office
Rockefeller family
$21K
0.00%
#3719 of 4729+300.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CALC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 16,089,428 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

34 filers8,842,525 shares$11.64M value54.96% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 407,801 $2.69M 23.09% 2.53% 2025-12-31
2 Woodline Partners LP 2,489,729 $2.56M 22.03% 15.47% 2026-06-30
3 HEIGHTS CAPITAL MANAGEMENT, INC 1,556,081 $1.60M 13.77% 9.67% 2026-06-30
4 Squadron Capital Management LLC 1,244,864 $1.28M 11.02% 7.74% 2026-06-30
5 STEMPOINT CAPITAL LP 1,244,864 $1.20M 10.27% 7.74% 2026-06-30
6 Stonepine Capital Management, LLC 622,432 $544.94K 4.68% 3.87% 2026-06-30
7 MERITAGE PORTFOLIO MANAGEMENT 61,539 $405.54K 3.48% 0.38% 2025-12-31
8 L1 Global Manager Pty Ltd 248,972 $256.44K 2.20% 1.55% 2026-06-30
9 Sheets Smith Investment Management 51,100 $157.17K 1.35% 0.32% 2025-09-30
10 Morgan Stanley Custodian 143,245 $147.54K 1.27% 0.89% 2026-06-30
11 Geode Capital Management, LLC Custodian 110,477 $113.85K 0.98% 0.69% 2026-06-30
12 RENAISSANCE TECHNOLOGIES LLC 97,300 $100.22K 0.86% 0.60% 2026-06-30
13 Vanguard Capital Management LLC 88,956 $91.62K 0.79% 0.55% 2026-06-30
14 180 WEALTH ADVISORS, LLC 83,400 $85.90K 0.74% 0.52% 2026-06-30
15 XTX Topco Ltd 78,288 $80.64K 0.69% 0.49% 2026-06-30
16 Cambridge Investment Research Advisors, Inc. 60,000 $62.00K 0.53% 0.37% 2026-06-30
17 HRT FINANCIAL LP 46,825 $48.00K 0.41% 0.29% 2026-06-30
18 Vanguard Fiduciary Trust Co 45,829 $47.20K 0.41% 0.28% 2026-06-30
19 Susquehanna International Group, LLP Custodian 43,968 $45.29K 0.39% 0.27% 2026-06-30
20 Rockefeller Capital Management L.P. Custodian 20,000 $20.60K 0.18% 0.12% 2026-06-30
21 GSA CAPITAL PARTNERS LLP 17,469 $18.00K 0.15% 0.11% 2026-06-30
22 State Street Corp 17,073 $17.59K 0.15% 0.11% 2026-06-30
23 TritonPoint Partners, LLC 15,119 $15.57K 0.13% 0.09% 2026-06-30
24 Scientech Research LLC 15,105 $15.56K 0.13% 0.09% 2026-06-30
25 Northern Trust Corp Custodian 12,530 $12.91K 0.11% 0.08% 2026-06-30
1 filers$73.95K notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $73.95K 100.00% 2026-06-30
1 filers$206 notional
# Filer Notional Value % of Total Period
1 Simplex Trading, LLC Custodian $206 100.00% 2026-06-30

CALC Insider Trading (Form 4)

Latest: 2026-10-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-05 Evgeny Zaytsev Director Grant (A) +20,000 opt — EDGAR
2026-10-05 Frederic Guerard Director Grant (A) +20,000 opt — EDGAR
2026-10-05 Alan Glicklich Director Grant (A) +20,000 opt — EDGAR
2026-10-05 Robert N Wilson Director Grant (A) +20,000 opt — EDGAR
2026-10-05 Allan Shaw Director Grant (A) +20,000 opt — EDGAR
2026-09-28 Sudarshan Hebbar Chief Medical Officer Grant (A) +180,000 opt — EDGAR
2026-09-28 A. Rachel Leheny CHIEF EXECUTIVE OFFICER Grant (A) +360,000 opt — EDGAR
2026-09-28 Kenneth A. Stauderman Chief Scientific Officer Grant (A) +180,000 opt — EDGAR
2026-09-28 Stephen Bardin Chief Financial Officer Grant (A) +190,000 opt — EDGAR
2026-08-24 ALAFI CAPITAL CO LLC 10%+ Owner Award (A) — — EDGAR
2026-08-21 A. Rachel Leheny CHIEF EXECUTIVE OFFICER Grant (A) +373,458 RSU — EDGAR
2026-08-21 Eric W Roberts CHIEF BUSINESS OFFICER Grant (A) +373,458 RSU — EDGAR
2026-08-21 Allan Shaw Director Grant (A) +10,000 opt — EDGAR
2026-08-21 Evgeny Zaytsev Director Grant (A) +2,910,534 opt — EDGAR
2026-08-21 Alan Glicklich Director Grant (A) +10,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CALC Insider Holdings

9 insiders · @ $1.30
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 ALAFI CAPITAL CO LLC 10%+ Owner 1,022,469 $1.33M $0 1 2026-08-24
2 Robert N Wilson Director 320,930 $417.2K $222.4K 11 2026-10-05
3 Fred A Middleton Director 196,652 $255.6K $2.77M 9 2026-06-29
4 Eric W Roberts CHIEF BUSINESS OFFICER 136,509 $177.5K $407.3K 40 2026-08-21
5 A. Rachel Leheny CHIEF EXECUTIVE OFFICER 76,777 $99.8K $85.1K 22 2026-09-28
6 Sudarshan Hebbar Chief Medical Officer 37,205 $48.4K $168.9K 12 2026-09-28
7 Frederic Guerard Chief Executive Officer 22,222 $28.9K $0 5 2026-10-05
8 Stephen Bardin Chief Financial Officer 8,600 $11.2K $4.7K 5 2026-09-28
9 Kenneth A. Stauderman Chief Scientific Officer 2,589 $3.4K $2.2K 8 2026-09-28
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

CALC Board & Officers

As of SEC filings through Oct 5, 2026

Directors 7

Officers 6

10% owners 3

Changes in the last 10 years (67)
Aug 21, 2026A. Rachel Leheny no longer listed as a 10% owner in SEC filings
Jul 2, 2026The company announced the departure of Fred A Middleton from the board in an SEC filing
Jul 2, 2026Evgeny Zaytsev became a director
Jun 25, 2026Alafi Capital Co LLC became a 10% owner
Jan 15, 2025Alan Glicklich became a director
Jan 10, 2025The company announced the departure of Eric Bjerkholt from the board in an SEC filing
Nov 13, 2024Stephen Bardin became Chief Financial Officer
Apr 22, 2024Frederic Guerard no longer listed as Chief Executive Officer in SEC filings
Mar 20, 2023Valence Investments SPV VI, LLC became a 10% owner
Mar 20, 2023Valence Investments SPV V, LLC became a 10% owner
Mar 20, 2023Valence Investments SPV IV LLC became a 10% owner
Mar 20, 2023Sudarshan Hebbar became Chief Medical Officer
Mar 20, 2023Sanderling Ventures VII, L.P. became a 10% owner
Mar 20, 2023Sanderling Ventures VII Annex Fund, L.P. became a 10% owner
Mar 20, 2023Sanderling Ventures VII (Canada), L.P. became a 10% owner
Mar 20, 2023Sanderling Ventures Management VII became a 10% owner
Mar 20, 2023Sanderling Ventures Management VI became a 10% owner
Mar 20, 2023Sanderling Venture Partners VI LP became a 10% owner
Mar 20, 2023Sanderling Venture Partners VI Co Investment Fund LP became a 10% owner
Mar 20, 2023Sanderling VI Limited Partnership became a 10% owner
Not reported recently (23)
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.35
TTM Revenue
—
TTM Net Income
$-21.24M
TTM Op. Cash Flow
$-19.11M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30—$-7.65M$-0.45$-4.62M
Q1 '262026-03-31—$4.98M$0.30$-4.86M
Q4 '252025-12-31—$-10.76M$-0.69$-4.85M
Q3 '252025-09-30—$-7.80M$-0.52$-4.78M
Q2 '252025-06-30—$-5.96M$-0.40$-6.67M
Q1 '252025-03-31—$-5.04M$-0.36$-4.88M
Q4 '242024-12-31—$-4.26M$-0.34$-4.97M
Q3 '242024-09-30—$-5.62M$-0.50$-4.67M
Q2 '242024-06-30—$-3.95M$-0.36$-6.79M
Q1 '242024-03-31—$130.00K$0.01$-4.71M
Q4 '232023-12-31—$-4.15M$-0.23$-3.61M
Q3 '232023-09-30—$-4.62M$-0.82$-4.57M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-11
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
3.79
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-385.3%
ROA
-108.9%
Div Yield
0.00%
FCF Yield
-91.35%
Debt/Equity
1.67
Current Ratio
—
Market Cap
$20.92M
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
86.43K
SI % of Float
0.49%
Days to Cover
1.50
Short Vol Ratio
76.3%
Free Float
17.74M
Float %
52.0%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-25